Insilico, the latest startup to join the Skolkovo Foundation’s biomed cluster, aims to apply artificial intelligence to extend human productive longevity and transform the pharmaceutical industry. Alex Zhavoronkov, who founded the U.S. company Insilico...
As the world discusses the ethics of growing human organs in pigs , scientists gathered at the Skolkovo Foundation last week to discuss an equally divisive topic: that of human genome modification. Scientists in the U.S. are currently making headlines...
Russian pharmaceutical companies looking to enter the U.K. market – and vice versa – will meet with their British counterparts at a two-day conference at the Skolkovo innovation centre next week to forge new partnerships in developing innovative...
The Skolkovo Foundation and Cuba’s Centre for Genetic Engineering and Biotechnology have signed a strategic partnership agreement, hailed by Skolkovo President Viktor Vekselberg as the start of a new era. Four memorandums were signed in Havana outlining...
As Russia marked Russian Science Day on February 8, a delegation from Germany’s Helmholtz Association of research centres visited the Skolkovo Institute of Science and Technology (Skoltech) to discuss ways of improving cooperation between the two countries’...
The winners of the far eastern stage of the Skolkovo Foundation’s Startup Tour have been announced in Vladivostok, with projects in the biomedicine category leading the way. About 120 projects were presented to the jury in the categories of IT, industrial...
Skolkovo has begun accepting applications from startup companies in the agriculture business and expects its first residents by the end of the year, opening up new avenues of research that experts say are of critical importance for biotech in Russian and beyond...